FDA Approves Widaplik (telmisartan, amlodipine and indapamide) for the Treatment of Hypertension
London, UK, Boston, MA, 9 June 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing unmet needs in cardiometabolic disease, today announces that the US Food and Drug Administration (FDA) has approved...
London, UK, Boston, MA, 9 June 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing unmet needs in cardiometabolic disease, today announces that the US Food and Drug Administration (FDA) has approved...
